Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

OBJECTIVES: Pulmonary fibrosis is a leading cause of death in systemic sclerosis (SSc). This report examines the differences at baseline and over 12 months between patients with limited versus diffuse cutaneous SSc who participated in the Scleroderma Lung Study. METHODS: SSc patients (64 limited; 94...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Clements, P J, Roth, M D, Elashoff, R, Tashkin, D P, Goldin, J, Silver, R M, Sterz, M, Seibold, J R, Schraufnagel, D, Simms, R W, Bolster, M, Wise, R A, Steen, V, Mayes, M D, Connelly, K, Metersky, M, Furst, D E
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2007
Matèries:
Extended Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2095310/
https://ncbi.nlm.nih.gov/pubmed/17485423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.069518
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars